Navigation Links
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Date:9/21/2009

BA; presentation embargoed until 12:15 CEST Sept. 22, 2009). In this study of 2,049 patients with advanced breast cancer, denosumab met all primary and secondary endpoints and demonstrated superior efficacy compared to Zometa in the treatment of bone metastases.

Webcast Information

Denosumab data presented at ECCO-ESMO today will be discussed by Roger M. Perlmutter, M.D., Ph.D., executive vice president of Research and Development at Amgen at the UBS Global Life Sciences Conference in New York this morning at 8:30 a.m. Eastern Time (ET). Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site at www.amgen.com, under Investors.

An analyst/investor event will also be held from the Congress on September 24th, at 6:30 a.m. ET to discuss data presented at ECCO-ESMO. A webcast of the event can be found on Amgen's Web site at www.amgen.com, under Investors. The audio webcast will be archived and available for replay for at least 72 hours.

Study Design

This was an international, Phase 3, randomized, double-blind, active-comparator-controlled study comparing denosumab with Zometa in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. Patients enrolled in this event-driven study were randomized in a one-to-one ratio to receive either 120 mg of denosumab subcutaneously every four weeks (Q4W) or Zometa administered intravenously at a dose of 4 mg delivered as a single, 15-minute infusion every four weeks.

In clinical trials thus far to test new medications for bone metastases, treatment success has been measured by whether the bone complications, or SREs, caused by the tumor a
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 New-generation electronic designs are focused ... lightweight. Simultaneously, circuitry is increasing the number of ... which it performs at. Connecting cables from the ... equipment, such as cameras or detectors, must be ... connectors include custom cable designs for high-quality signal ...
(Date:6/18/2013)... 2013 Remedy Informatics, a leading provider ... sciences research, today announced it has been awarded ... 70 supply contract (GS-35F-367AA, effective May 7, 2013) ... solutions to government agencies at federal, state and ... has placed its products and services on the ...
(Date:6/18/2013)... 2013  Pro football player and 2012 most valuable ... expert Jo Frost have potentially life-threatening (severe) ... fully integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: ... significant health problem. In recognition of the 25 th ... (FDA) approval of EpiPen ® (epinephrine) Auto-Injector, ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8
... PORTLAND, Ore., June 8, 2011 A new report ... enough about rogue online pharmacies selling addictive medications without a ... Internet pharmacy monitoring service LegitScript.com , analyzes the DEA,s ... The 2009 law was named after an 18-year ...
... June 8, 2011 Reportlinker.com announces that ... in its catalogue: Asia-Pacific ... http://www.reportlinker.com/p0336550/Asia-Pacific-Drug-Delivery-Devices-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ... to 2017 Summary ...
Cached Medicine Technology:Report Criticizes DEA for Failing to Address Online Pharmacy Problem 2Reportlinker Adds Asia-Pacific Drug Delivery Devices Market Outlook to 2017 2
(Date:6/18/2013)... June 18, 2013 A new $119 ... The burgeoning aquaculture industry is redefining the way consumers ... the most acclaimed personal culinary chefs on the Emerald ... benefits of sustainable seafood and the promising industry of ... these days. Many consumers strive to fully partake in ...
(Date:6/18/2013)... 2013 David Connett, DO, vice dean, ... for the College of Osteopathic Medicine of the Pacific ... elected president of the Osteopathic Medical Board of ... appointed Connett, a 1984 alumnus of COMP, to the ... Connett to the position during a conference call. , ...
(Date:6/18/2013)... New York, N.Y., June 18, 2013 -- Lauren ... its novel V-Smart nanovesicle platform technology, announced today ... Innovator in Drug Delivery with its V-Smart Platform, ... new report by MCD Group. , ... Profiles of Start-ups and Emerging Companies ," features ...
(Date:6/18/2013)... Medical Center enrolled their first patients in the ROADSTER ... less-invasive procedure to help clear blockages in carotid arteries ... 300,000 people in the United States are diagnosed with ... untreated, these blockages can slow or even stop blood ... also known as a "brain attack." , Current ...
(Date:6/18/2013)... are scrambling to gather data for the FDA to ... brain injury in the United States. The University of ... in the Journal of Neurotrauma that it ... instead of one., Jeffrey J. Bazarian, M.D., M.P.H., an ... the first to show that measuring a combination of ...
Breaking Medicine News(10 mins):Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2
... A groundbreaking new study published in,the November 2008 issue ... of lower energy dense breakfast have improved diet,quality, and ... weight. The,study found that those who enjoy a less ... important vitamins and minerals and lower in,saturated fat and ...
... U-M Health Minute: Today,s top health issues and medical research, ... diabetes for nine years, and he knows the importance of ... the feet., "Knowing some of the warning signs of ... things immediately I knew would prevent larger,issues, I see the ...
... Italian study shows that gains with shorter intervention ... News) -- Heart attack survivors can significantly reduce ... in an intensive, long-term prevention program, according to ... After a standard period of post-heart attack rehabilitation, ...
... The Grand Opening Celebration of Ocean,Blue Plastic ... 7:00 until,10:00 p.m. Ocean Blue Plastic Surgery is ... prestigious addresses. Guests are invited to enjoy the,Carlos ... Surgery while,sampling hors d,oeuvres and sipping cocktails provided ...
... Nov. 11 WebMD Health Corp. (Nasdaq:,WBMD) today announced ... in the November/December issue of WebMD the Magazine. The ... face health,issues with the vision and drive to inspire ... Movement to Help End Cancer, Laura Ziskin, breast ...
... Book Summaries, the free,book summary service created by ... subscriber milestone. The service delivers free, downloadable,summaries of ... Dr. Bruce,Lipton and "Appetite for Profit" by Michele ... Launched in mid-2008, the Health Book Summaries service ...
Cached Medicine News:Health News:Breakfast Improves Overall Diet Quality and May Help with Weight Management 2Health News:Breakfast Improves Overall Diet Quality and May Help with Weight Management 3Health News:Foot Problems Common Among People With Diabetes 2Health News:Foot Problems Common Among People With Diabetes 3Health News:Long-Term Help Regimen Cut Heart Attack Recurrence 2Health News:Ocean Blue Plastic Surgery to Open This Month on Brickell Avenue 2Health News:WebMD Announces 2008 Health Heroes 2Health News:WebMD Announces 2008 Health Heroes 3Health News:Health Book Summaries Subscriber Base Grows to 60,000 Readers as Health Consumers Applaud Free Format 2
The Oxoid Biochemical Identification System (O.B.I.S.) albicans is a simple, non-hazardous colorimetric test for the differentiation of Candida albicans from other yeast species....
Next-generation real-time polymerase chain reaction (PCR) testing for clinical laboratories. , ,The COBAS TaqMan 48 Analyzer allows automated real-time amplification and detection of DNA or RNA f...
... HealthMatics EHR Electronic Health Record streamlines ... clinical workflow automation. A flexible and ... both clinical and financial benefits. HealthMatics ... within the practice and with outside ...
... revolutionary "blended model EMR system designed for ... your office and on-line simultaneously. Designed by ... software engineers, meridianEMR combines the power of ... modular medical EMR that provides physicians with:, ...
Medicine Products: